Merck
  • Home
  • Search Results
  • Palmitate-induced inflammatory pathways in human adipose microvascular endothelial cells promote monocyte adhesion and impair insulin transcytosis.

Palmitate-induced inflammatory pathways in human adipose microvascular endothelial cells promote monocyte adhesion and impair insulin transcytosis.

American journal of physiology. Endocrinology and metabolism (2015-05-07)
Nicolas J Pillon, Paymon M Azizi, Yujin E Li, Jun Liu, Changsen Wang, Kenny L Chan, Kathryn E Hopperton, Richard P Bazinet, Bryan Heit, Philip J Bilan, Warren L Lee, Amira Klip
ABSTRACT

Obesity is associated with inflammation and immune cell recruitment to adipose tissue, muscle and intima of atherosclerotic blood vessels. Obesity and hyperlipidemia are also associated with tissue insulin resistance and can compromise insulin delivery to muscle. The muscle/fat microvascular endothelium mediates insulin delivery and facilitates monocyte transmigration, yet its contribution to the consequences of hyperlipidemia is poorly understood. Using primary endothelial cells from human adipose tissue microvasculature (HAMEC), we investigated the effects of physiological levels of fatty acids on endothelial inflammation and function. Expression of cytokines and adhesion molecules was measured by RT-qPCR. Signaling pathways were evaluated by pharmacological manipulation and immunoblotting. Surface expression of adhesion molecules was determined by immunohistochemistry. THP1 monocyte interaction with HAMEC was measured by cell adhesion and migration across transwells. Insulin transcytosis was measured by total internal reflection fluorescence microscopy. Palmitate, but not palmitoleate, elevated the expression of IL-6, IL-8, TLR2 (Toll-like receptor 2), and intercellular adhesion molecule 1 (ICAM-1). HAMEC had markedly low fatty acid uptake and oxidation, and CD36 inhibition did not reverse the palmitate-induced expression of adhesion molecules, suggesting that inflammation did not arise from palmitate uptake/metabolism. Instead, inhibition of TLR4 to NF-κB signaling blunted palmitate-induced ICAM-1 expression. Importantly, palmitate-induced surface expression of ICAM-1 promoted monocyte binding and transmigration. Conversely, palmitate reduced insulin transcytosis, an effect reversed by TLR4 inhibition. In summary, palmitate activates inflammatory pathways in primary microvascular endothelial cells, impairing insulin transport and increasing monocyte transmigration. This behavior may contribute in vivo to reduced tissue insulin action and enhanced tissue infiltration by immune cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
纯乙醇, 200 proof, anhydrous, ≥99.5%
Sigma-Aldrich
台盼蓝 溶液, 0.4%, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
牛血清白蛋白 来源于牛血清, fatty acid free, low endotoxin, lyophilized powder, BioReagent, suitable for cell culture, ≥96% (agarose gel electrophoresis)
Sigma-Aldrich
纯乙醇, 190 proof, ACS spectrophotometric grade, 95.0%
Sigma-Aldrich
纯乙醇, 190 proof, meets USP testing specifications
Sigma-Aldrich
3,3′,5,5′-四甲基联苯胺, ≥99%
Sigma-Aldrich
乙醇, anhydrous, denatured
Sigma-Aldrich
棕榈酸钠, ≥98.5%
Sigma-Aldrich
台盼蓝, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
3,3′,5,5′-四甲基联苯胺, ≥98% (TLC)
Sigma-Aldrich
棕榈油酸, ≥98.5% (GC), liquid
Sigma-Aldrich
3,3′,5,5′-四甲基联苯胺, ≥98.0% (NT)
Sigma-Aldrich
台盼蓝, Dye content 60 %
Sigma-Aldrich
Insulin-FITC labeled human, recombinant, expressed in yeast, lyophilized powder
Sigma-Aldrich
3,3′,5,5′-四甲基联苯胺, tablet, 1 mg substrate per tablet
Supelco
10% (v/v) 乙醇标准品, 10 % (v/v) in H2O, analytical standard
Sigma-Aldrich
小豆蔻明, ≥98% (HPLC)
Sigma-Aldrich
80% v/v 乙醇固定液, suitable for fixing solution (blood films)
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Icam1
Sigma-Aldrich
MISSION® esiRNA, targeting human ICAM1